Tradestie Institutional Equity Comparison Engine

COCP vs ECOR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

COCP Overall Edge

COCP Captures Institutional Edge (1โ€“1 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Cocrystal Pharma, Inc. Common Stock (COCP) driven by superior Growth & Margin while ECOR counters with relative strength in Momentum & Technical. Fundamentally, COCP trades at N/M Forward P/E with -2646.0% operating margin (+26.9% YoY revenue) versus ECOR at N/M Forward P/E and -33.1% operating margin (+11.5% YoY). In options structure, COCP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ECOR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
COCP N/M vs ECOR N/M Fwd P/E
Growth & Margin Winner COCP
Op Margin -2646.0% vs -33.1% ยท YoY +26.9% vs +11.5%
Momentum & Technical Winner ECOR
1Y -4.9% vs -4.0% ยท 52W Pos 16% vs 6%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
COCP NASDAQ
Cocrystal Pharma, Inc. Common Stock
Pharmaceutical Preparations
$0.97
-0.72% 1D
Market Cap $18.5M
1M Return +2.79%
1Y Return -4.91%
Forward P/E N/M
Unified AI Score
45.4 / 100 HOLD
Tech 44.0 Fund 50.0 Flow 50.0 Mom 54.0
ECOR NASDAQ
electroCore, Inc. Common Stock
Electromedical & Electrotherapeutic Apparatus
$4.85
-6.19% 1D
Market Cap $47.7M
1M Return -34.01%
1Y Return -3.96%
Forward P/E N/M
Unified AI Score
56.8 / 100 HOLD
Tech 68.0 Fund 53.0 Flow 50.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: COCP -4.91% ECOR -3.96% Spread: +0.95 pp (ECOR Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period COCP Revenue ECOR Revenue COCP Op. Margin ECOR Op. Margin Margin Edge
FY2018 N/A $0M N/A -5494.1% ECOR
FY2019 $10M $0M -737.4% -1928.2% COCP
FY2020 $0M $0M -476.0% -707.9% COCP
FY2021 N/A $10M N/A -367.7% ECOR
FY2022 N/A $10M N/A -266.2% ECOR
FY2023 N/A $20M N/A -120.2% ECOR
FY2024 N/A $30M N/A -48.3% ECOR
FY2025 N/A $30M N/A -41.1% ECOR

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: COCP (5) vs ECOR (3)
Institutional Metric COCP ECOR Criterion Row Winner
Market Capitalization Scale $18.5M $47.7M Larger Scale ECOR
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +26.9% +11.5% Higher Growth COCP
Operating Margin (TTM) Profitability -2646.0% -33.1% Higher Margin ECOR
Net Profit Margin Profitability 0.0% -33.5% Higher Margin COCP
Return on Equity (ROE) Capital Efficiency -219.1% -478.7% Higher ROE COCP
52-Week Range Position Momentum 16% ($1โ€“$2) 6% ($4โ€“$13) Stronger Trend COCP
Beta / 30D Volatility Risk Regime 1.01ฮฒ ยท 55% Vol 1.52ฮฒ ยท 155% Vol Lower Realized Risk COCP
Unified Institutional Score Composite Signal 45.4 / 100 (HOLD) 56.8 / 100 (HOLD) Higher Composite ECOR

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full COCP vs ECOR Buy Guide
COCP UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live COCP Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ECOR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ECOR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither COCP nor ECOR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.